Excela Health Orthopedics Latrobe, PA - 15650

Excela Health Orthopedics is categorized under Blood Related Health Services in Latrobe, PA .

Excela Health Orthopedics was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Blood Related Health Services business, which does work in the B2C market, and is classified as a Blood Related Health Services, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Jan Harley, Office Manager at the company’s branch by writing to 911 Ligonier St # 3, Latrobe, Pennsylvania PA 15650 or by phoning (724) 537-9010. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Excela Health Orthopedics
Contact Person: Jan Harley, Office Manager
Address: 911 Ligonier St # 3, Latrobe, Pennsylvania 15650
Phone Number: (724) 537-9010
Website Address: excelahealth.org
Annual Revenue (USD): $1.000.000 to $2.499.999
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Blood Related Health Services
SIC Code: 8099
NAICS Code: 6211110
Share This Business:

Excela Health Orthopedics was started in 0 to provide professional Blood Related Health Services under the SIC code 8099 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Jan Harley, Office Manager for inquiries that concern Excela Health Orthopedics by calling the company number (724) 537-9010, as your correspondence is most welcome. Additionally, the physical location of the branch of Excela Health Orthopedics can be found at the coordinates 40.31597,-79.38414 as well as the street address 911 Ligonier St # 3 in Latrobe, Pennsylvania 15650.

For its online presence, you may visit Excela Health Orthopedics’s website at excelahealth.org and engage with its social media outlets through on Twitter and on Facebook.